Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
EBTC
|
Luis M Pedroso
Director |
BUY
Open market or private purchase
|
Direct | 91 Added 0.42% |
$2,409
$26.47 p/Share
|
Dec 01
2020 |
ARCT
|
Pad Chivukula
Chief Scientific Officer & COO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.42% |
$961,900
$96.19 p/Share
|
Dec 01
2020 |
TPIC
|
Daniel G Weiss |
SELL
Open market or private sale
|
Indirect | 61,376 Reduced 26.59% |
$2,626,893
$42.8 p/Share
|
Dec 01
2020 |
STOK
|
Huw M. Nash
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 5,700 Reduced 100.0% |
$289,845
$50.85 p/Share
|
Dec 01
2020 |
STOK
|
Huw M. Nash
Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,700 Added 50.0% |
$12,483
$2.19 p/Share
|
Dec 01
2020 |
MBWM
|
Robert B Kaminski |
SELL
Payment of exercise price or tax liability
|
Direct | 1,714 Reduced 3.18% |
$42,919
$25.04 p/Share
|
Dec 01
2020 |
MBWM
|
Lonna Wiersma
SVP, HUMAN RESOURCES DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct | 786 Reduced 9.63% |
$19,681
$25.04 p/Share
|
Dec 01
2020 |
MBWM
|
Robert T. Worthington
SVP, CRO, SECRETARY, AND GC |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 28.35% |
$87,640
$25.04 p/Share
|
Dec 01
2020 |
BCYC
|
Lee Kalowski
President and CFO |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 100.0% |
$168,750
$22.5 p/Share
|
Dec 01
2020 |
BCYC
|
Lee Kalowski
President and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 7,500 Added 50.0% |
$11,700
$1.56 p/Share
|
Dec 01
2020 |
FMNB
|
Kevin J Helmick
President & CEO |
BUY
Open market or private purchase
|
Direct | 39 Added 0.04% |
$502
$12.88 p/Share
|
Dec 01
2020 |
FMNB
|
Terry A Moore |
BUY
Open market or private purchase
|
Direct | 372 Added 0.86% |
$4,791
$12.88 p/Share
|
Dec 01
2020 |
FMNB
|
Edward Muransky |
BUY
Open market or private purchase
|
Direct | 291 Added 0.75% |
$3,748
$12.88 p/Share
|
Dec 01
2020 |
FMNB
|
Joseph W Sabat
VP/Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct | 97 Added 0.54% |
$1,249
$12.88 p/Share
|
Dec 01
2020 |
FMNB
|
Amber B Wallace
Sr VP/Chief Retail/Marketing |
BUY
Open market or private purchase
|
Direct | 15 Added 0.05% |
$193
$12.88 p/Share
|
Dec 01
2020 |
MOD
|
Neil David Brinker
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 186,794 Added 50.0% |
-
|
Dec 01
2020 |
QNST
|
Douglas Valenti
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,083 Reduced 0.53% |
$37,702
$18.1 p/Share
|
Dec 01
2020 |
QNST
|
Douglas Valenti
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,083 Added 0.53% |
$8,353
$4.01 p/Share
|
Dec 01
2020 |
CSTL
|
Bernhard E. Spiess
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 77.3% |
$1,998,800
$49.97 p/Share
|
Dec 01
2020 |
IGMS
|
Daniel Shin Yu Chen
Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 342 Reduced 0.29% |
$21,963
$64.22 p/Share
|
Dec 01
2020 |
IGMS
|
Daniel Shin Yu Chen
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 950 Added 0.8% |
$1,320
$1.39 p/Share
|
Dec 01
2020 |
BLFS
|
Michael Rice |
SELL
Open market or private sale
|
Direct | 813 Reduced 0.4% |
$28,853
$35.49 p/Share
|
Dec 01
2020 |
BLFS
|
Karen A. Foster
Chief Quality and Operations |
SELL
Open market or private sale
|
Direct | 166 Reduced 0.33% |
$5,891
$35.49 p/Share
|
Dec 01
2020 |
BLFS
|
Aby J. Mathew
EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 380 Reduced 0.21% |
$13,486
$35.49 p/Share
|
Dec 01
2020 |
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 3,236 Reduced 0.32% |
$141,478
$43.72 p/Share
|
Dec 01
2020 |
QTRX
|
John J Fry
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 141 Reduced 0.44% |
$6,165
$43.72 p/Share
|
Dec 01
2020 |
QTRX
|
Amol Chaubal
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 115 Reduced 0.45% |
$5,028
$43.72 p/Share
|
Dec 01
2020 |
QTRX
|
Dawn Mattoon
Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct | 158 Reduced 0.5% |
$6,908
$43.72 p/Share
|
Dec 01
2020 |
QTRX
|
Mark T. Roskey
SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct | 91 Reduced 0.41% |
$3,979
$43.72 p/Share
|
Dec 01
2020 |
FPI
|
John A Good
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 26.13% |
$80,300
$8.03 p/Share
|
Dec 01
2020 |
COWN
|
John J Holmes
CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 3,670 Reduced 1.81% |
$90,209
$24.58 p/Share
|
Dec 01
2020 |
COWN
|
Stephen Lasota
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 3,571 Reduced 1.54% |
$87,775
$24.58 p/Share
|
Dec 01
2020 |
COWN
|
Owen S Littman
GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct | 3,571 Reduced 1.93% |
$87,775
$24.58 p/Share
|
Dec 01
2020 |
COWN
|
Jeffrey M Solomon
CHAIR AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 16,973 Reduced 2.05% |
$417,196
$24.58 p/Share
|
Dec 01
2020 |
ATEC
|
James L L Tullis |
BUY
Other acquisition or disposition
|
Indirect | 116,355 Added 50.0% |
-
|
Dec 01
2020 |
ATEC
|
James L L Tullis |
SELL
Other acquisition or disposition
|
Indirect | 600,000 Reduced 34.41% |
-
|
Dec 01
2020 |
MOV
|
Vivian D Elia
Senior VP Human Resources |
BUY
Grant, award, or other acquisition
|
Direct | 3,000 Added 9.86% |
-
|
Dec 01
2020 |
MOV
|
Sallie A Demarsilis
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,500 Added 12.77% |
-
|
Dec 01
2020 |
MOV
|
Alexander Grinberg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,770 Added 12.74% |
-
|
Dec 01
2020 |
MOV
|
Behzad Soltani
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,200 Added 24.65% |
-
|
Dec 01
2020 |
MOV
|
Mitchell Cole Sussis
Senior VP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 3,300 Added 12.42% |
-
|
Dec 01
2020 |
CDLX
|
Clifford Sosin
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2 Added 0.0% |
$240
$120.0 p/Share
|
Dec 01
2020 |
ATEX
|
Elaine Gangeri
Chief Acc Officer, Treasurer |
SELL
Open market or private sale
|
Direct | 1,018 Reduced 3.6% |
$30,642
$30.1 p/Share
|
Dec 01
2020 |
CCF
|
Dana Allen Mohler Faria
Director |
BUY
Grant, award, or other acquisition
|
Direct | 16 Added 0.59% |
-
|
Dec 01
2020 |
DCPH
|
Michael Douglas Taylor
Director |
SELL
Open market or private sale
|
Direct | 19,000 Reduced 100.0% |
$1,169,450
$61.55 p/Share
|
Dec 01
2020 |
DCPH
|
Michael Douglas Taylor
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 19,000 Added 50.0% |
$35,910
$1.89 p/Share
|
Dec 01
2020 |
HCAT
|
Linda Llewelyn
Chief People Officer |
SELL
Open market or private sale
|
Direct | 1,570 Reduced 6.19% |
$54,934
$34.99 p/Share
|
Dec 01
2020 |
HCAT
|
Daniel H. Orenstein
General Counsel |
SELL
Open market or private sale
|
Direct | 6,084 Reduced 15.21% |
$212,757
$34.97 p/Share
|
Dec 01
2020 |
HCAT
|
Daniel D. Burton
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,482 Reduced 2.12% |
$156,780
$34.98 p/Share
|
Dec 01
2020 |
HCAT
|
James Patrick Nelli Jr.
President |
SELL
Open market or private sale
|
Direct | 33,582 Reduced 27.79% |
$1,188,803
$35.4 p/Share
|
Dec 01
2020 |